Industry News
Pharmaceutical Industry News
How Private Equity Oversees the Ethics of Drug Research
Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety.
Rite Aid Closes Its Remaining Stores
The company said it had closed its remaining 89 stores this week after struggling for years to stay in business and filing for bankruptcy protection twice.
Katie Carr of Swoop discusses…
Katie Carr of Swoop discusses evolving privacy laws, TV’s role in patient trust and the future of in-house measurement
The FDA unveiled a new pilot…
The FDA unveiled a new pilot program that aims to speed up review times for generic drugmakers who test and manufacture their products in the U.S. Separately, the agency met with industry stakeholders this week
Patients and providers often enter…
Patients and providers often enter the exam room misaligned. A 360° data strategy may be pharma’s missing link.
OptimizeRx CEO highlights earlier…
OptimizeRx CEO highlights earlier diagnosis, smarter strategies
In a letter inked to the U.K.’s…
In a letter inked to the U.K.’s Competition and Markets Authority, three advocacy organizations called the recent string of Big Pharma companies pulling their U.K. investments a coordinated scheme for "anti-competitive purposes."
The FDA has approved Jazz…
The FDA has approved Jazz Pharmaceuticals’ Zepzelca, used in combination with Roche’s Tecentriq, as a first-line maintenance treatment in extensive-stage small cell lung cancer
The initial part of the up-to-$339…
The initial part of the up-to-$339 million funding will largely be used to establish U.S. manufacturing for the non-vaccine flu preventive candidate, with additional options tied to further clinical studies, Cidara said.
GSK has successfully appealed…
GSK has successfully appealed a ruling by the U.K. marketing watchdog that determined a trio of its COVID-19 vaccine press releases had brought discredit on the pharma industry.
Sealed court documents obtained by…
Sealed court documents obtained by Fierce Biotech reveal how Novo Nordisk and Singapore's KBP Biosciences went from partners in a $1.3 billion deal to legal foes. Takeda has decided to cease all research work in
Artificial intelligence is…
Artificial intelligence is redefining industries at an unprecedented pace—and healthcare is no exception. But as algorithms grow smarter and adoption accelerates, leaders face a pressing question: how do we embrace the possibilities of AI without
Vaxcyte is paying Thermo Fisher…
Vaxcyte is paying Thermo Fisher Scientific up to $1 billion to access vaccine fill-finish capacity at the CDMO’s production facility in Greenville, North Carolina. Vaxcyte positioned the deal as a “long-term U.S. commercial manufacturing commitment.”
Chris Paquette sees data…
Chris Paquette sees data integration, personalization and cross-team alignment reshaping the industry
The FDA agreed to re-review…
The FDA agreed to re-review Vanda's previously rejected bid to market its Hetlioz in jet lag disorder, which has been the center of a years-long legal dispute between the two.
In the phase 3 Vesalius-CV study,…
In the phase 3 Vesalius-CV study, Repatha helped significantly curb the risk of major adverse cardiovascular events over standard treatment alone in people who hadn’t had a heart attack or stroke before, Amgen announced.
Vice president Michael Deichmiller…
Vice president Michael Deichmiller says trust, data and a media-first approach are reshaping the industry
Both Acadia Pharmaceuticals and…
Both Acadia Pharmaceuticals and e-therapeutics pulled back the curtain this week on new looks for their respective corporate brand identities.
Director says omnichannel…
Director says omnichannel strategies and patient-first approaches will define the future
BeOne Medicines and AbbVie have…
BeOne Medicines and AbbVie have decided to voluntarily dismiss the patent lawsuit the Big Pharma firm brought against its competitor over their BTK inhibitors.